One report noted coordinated over-expression of TNF-α, IL-1β, and chemokines (CCL2, CCL5) in breast tumors, which was associated with epithelial–mesenchymal transition (EMT) and invasive behavior. The gene discussed is IL1B; the disease is breast neoplasm.